vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and PARKE BANCORP, INC. (PKBK). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $22.7M, roughly 1.7× PARKE BANCORP, INC.). PARKE BANCORP, INC. runs the higher net margin — 48.8% vs 24.7%, a 24.1% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 35.7%). PARKE BANCORP, INC. produced more free cash flow last quarter ($39.0M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 22.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Parke Bancorp, Inc. is a U.S. regional bank holding company operating Parke Bank. It offers commercial and retail banking services including deposit products, mortgage loans, small business financing and personal lending, primarily serving customers across New Jersey and the Philadelphia metropolitan area.

CDXS vs PKBK — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.7× larger
CDXS
$38.9M
$22.7M
PKBK
Growing faster (revenue YoY)
CDXS
CDXS
+45.6% gap
CDXS
81.3%
35.7%
PKBK
Higher net margin
PKBK
PKBK
24.1% more per $
PKBK
48.8%
24.7%
CDXS
More free cash flow
PKBK
PKBK
$19.4M more FCF
PKBK
$39.0M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
22.6%
PKBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
PKBK
PKBK
Revenue
$38.9M
$22.7M
Net Profit
$9.6M
$11.1M
Gross Margin
94.8%
Operating Margin
27.1%
64.2%
Net Margin
24.7%
48.8%
Revenue YoY
81.3%
35.7%
Net Profit YoY
192.5%
49.8%
EPS (diluted)
$0.13
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
PKBK
PKBK
Q4 25
$38.9M
$22.7M
Q3 25
$8.6M
$21.0M
Q2 25
$15.3M
$18.7M
Q1 25
$7.5M
$17.4M
Q4 24
$21.5M
$16.8M
Q3 24
$12.8M
$15.6M
Q2 24
$8.0M
$15.5M
Q1 24
$17.1M
$15.1M
Net Profit
CDXS
CDXS
PKBK
PKBK
Q4 25
$9.6M
$11.1M
Q3 25
$-19.6M
$10.6M
Q2 25
$-13.3M
$8.3M
Q1 25
$-20.7M
$7.8M
Q4 24
$-10.4M
$7.4M
Q3 24
$-20.6M
$7.5M
Q2 24
$-22.8M
$6.5M
Q1 24
$-11.5M
$6.2M
Gross Margin
CDXS
CDXS
PKBK
PKBK
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
PKBK
PKBK
Q4 25
27.1%
64.2%
Q3 25
-220.3%
64.2%
Q2 25
-83.9%
59.0%
Q1 25
-271.6%
59.1%
Q4 24
-34.2%
58.0%
Q3 24
-129.0%
60.2%
Q2 24
-284.9%
56.7%
Q1 24
-69.6%
55.4%
Net Margin
CDXS
CDXS
PKBK
PKBK
Q4 25
24.7%
48.8%
Q3 25
-228.1%
50.6%
Q2 25
-86.6%
44.3%
Q1 25
-274.3%
44.6%
Q4 24
-48.4%
44.2%
Q3 24
-160.8%
48.1%
Q2 24
-285.2%
41.6%
Q1 24
-67.4%
40.7%
EPS (diluted)
CDXS
CDXS
PKBK
PKBK
Q4 25
$0.13
$0.93
Q3 25
$-0.22
$0.89
Q2 25
$-0.16
$0.69
Q1 25
$-0.25
$0.65
Q4 24
$-0.12
$0.61
Q3 24
$-0.29
$0.62
Q2 24
$-0.32
$0.53
Q1 24
$-0.16
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
PKBK
PKBK
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$324.5M
Total Assets
$147.8M
$2.2B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
PKBK
PKBK
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
PKBK
PKBK
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
PKBK
PKBK
Q4 25
$50.5M
$324.5M
Q3 25
$38.5M
$314.8M
Q2 25
$55.6M
$312.2M
Q1 25
$49.6M
$305.9M
Q4 24
$66.9M
$300.1M
Q3 24
$73.4M
$296.5M
Q2 24
$61.4M
$292.8M
Q1 24
$79.3M
$288.4M
Total Assets
CDXS
CDXS
PKBK
PKBK
Q4 25
$147.8M
$2.2B
Q3 25
$124.0M
$2.2B
Q2 25
$138.2M
$2.2B
Q1 25
$128.9M
$2.1B
Q4 24
$149.0M
$2.1B
Q3 24
$148.2M
$2.1B
Q2 24
$132.0M
$2.0B
Q1 24
$149.6M
$2.0B
Debt / Equity
CDXS
CDXS
PKBK
PKBK
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
PKBK
PKBK
Operating Cash FlowLast quarter
$20.1M
$39.6M
Free Cash FlowOCF − Capex
$19.6M
$39.0M
FCF MarginFCF / Revenue
50.3%
171.3%
Capex IntensityCapex / Revenue
1.3%
2.6%
Cash ConversionOCF / Net Profit
2.09×
3.57×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$63.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
PKBK
PKBK
Q4 25
$20.1M
$39.6M
Q3 25
$-7.7M
$11.4M
Q2 25
$-18.0M
$6.8M
Q1 25
$-13.8M
$7.0M
Q4 24
$-16.5M
$35.2M
Q3 24
$-13.0M
$9.4M
Q2 24
$-12.2M
$8.9M
Q1 24
$-7.8M
$8.3M
Free Cash Flow
CDXS
CDXS
PKBK
PKBK
Q4 25
$19.6M
$39.0M
Q3 25
$-7.9M
$11.2M
Q2 25
$-20.5M
$6.7M
Q1 25
$-15.1M
$6.6M
Q4 24
$-18.2M
$35.0M
Q3 24
$-14.0M
$9.4M
Q2 24
$-12.6M
$8.9M
Q1 24
$-8.9M
$8.3M
FCF Margin
CDXS
CDXS
PKBK
PKBK
Q4 25
50.3%
171.3%
Q3 25
-91.7%
53.5%
Q2 25
-133.6%
35.8%
Q1 25
-199.6%
38.0%
Q4 24
-85.0%
209.1%
Q3 24
-109.0%
60.0%
Q2 24
-157.5%
57.1%
Q1 24
-52.2%
55.1%
Capex Intensity
CDXS
CDXS
PKBK
PKBK
Q4 25
1.3%
2.6%
Q3 25
2.1%
0.5%
Q2 25
16.4%
0.3%
Q1 25
16.7%
2.2%
Q4 24
8.3%
0.7%
Q3 24
7.8%
0.1%
Q2 24
5.0%
0.2%
Q1 24
6.6%
0.1%
Cash Conversion
CDXS
CDXS
PKBK
PKBK
Q4 25
2.09×
3.57×
Q3 25
1.07×
Q2 25
0.82×
Q1 25
0.90×
Q4 24
4.75×
Q3 24
1.25×
Q2 24
1.38×
Q1 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons